---
schema_version: "secwatch.filing_event.v1"
accession: "0000883984-23-000007"
form_type: "8-K"
ticker: "ICUI"
cik: "0000883984"
company_name: "ICU MEDICAL INC/DE"
filed_at: "2023-02-27T23:59:59+00:00"
generated_at: "2026-06-19T00:16:46.963475+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# ICU Medical Q4 2022 revenue $578M, GAAP net loss $15.5M, provides FY23 guidance

## Summary
- Revenue $578.0M vs $340.5M YoY; GAAP net loss $(15.5)M ($(0.65)/diluted) vs net income $19.9M ($0.91) in Q4 2021.
- Adjusted diluted EPS $1.60 vs $1.82 YoY; adjusted EBITDA $96.4M vs $64.2M.
- GAAP gross margin 30% vs 37% YoY; gross profit $174.9M vs $127.5M.
- Fiscal year 2023 guidance announced but specific numbers not included in the excerpt.

## SEC filing metadata
- accession: 0000883984-23-000007
- form_type: 8-K
- ticker: ICUI
- cik: 0000883984
- company_name: ICU MEDICAL INC/DE
- filed_at: 2023-02-27T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/883984/000088398423000007/0000883984-23-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/883984/000088398423000007/icui-20230227.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000883984-23-000007
- JSON: https://secwatch.observer/filing/0000883984-23-000007.json
- Plain text: https://secwatch.observer/filing/0000883984-23-000007.txt

## Key facts
- Earnings Releases
  ICU MEDICAL INC/DE reported the fourth quarter of 2022 results: revenue $578.0 million, net income $(15.5) million, EPS $(0.65) per diluted share.
  - Period: the fourth quarter of 2022
  - Revenue: $578.0 million
  - Net income: $(15.5) million
  - EPS: $(0.65) per diluted share
  - Result: reported results
  source text: Fourth quarter 2022 revenue was $578.0 million, compared to $340.5 million in the same period last year. GAAP gross profit for the fourth quarter of 2022 was $174.9 million, as compared to $127.5 million in the same period last year. GAAP gross margin for the fourth quarter of 2022 was 30%, as compared to 37% in the same period last year. GAAP net loss for the fourth quarter of 2022 was $(15.5) million, or $(0.65) per diluted share, as compared to GAAP net income of $19.9 million, or $0.91 per diluted share, for the fourth quarter of 2021.
  evidence_url: https://www.sec.gov/Archives/edgar/data/883984/000088398423000007/0000883984-23-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.